Company Filing History:

15 out of 4,442

Eli Lilly and Company

patents

1 out of 134

Ligand Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1994-2011

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7935722 - Tetrahydrocarbazole derivatives useful as androgen receptor modulators (2011-05-03),

2. 7348359 - Retinoid X receptor modulators (2008-03-25),

3. 7250442 - Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators (2007-07-31),

4. 6265581 - Selective &bgr;3 adrenergic agonists (2001-07-24),

5. 6093735 - Selective .beta.-3 adrenergic agonists (2000-07-25),

6. 6075040 - Selective .beta..sub.3 adrenergic agonists (2000-06-13),

7. 6060492 - Selective .beta.3 adrenergic agonists (2000-05-09),

8. 6037475 - Synthesis of indolymaleimides (2000-03-14),

9. 5919946 - Synthesis of indolylmaleimides (1999-07-06),

10. 5859261 - Synthesis of indolylmaleimides (1999-01-12),

11. 5840738 - Selective .beta.-3 adrenergic agonists (1998-11-24),

12. 5808080 - Selective .beta.3 adrenergic agonists (1998-09-15),

13. 5786356 - Selective .beta.3 adrenergic agonists (1998-07-28),

14. 5643926 - Pyrazolidinone CCK and gastrin antagonists and pharmaceutical (1997-07-01),

15. 5300514 - Pyrazolidinone CCK and gastrin antagonists and pharmaceutical (1994-04-05),

Title: The Innovative Contributions of David Andrew Neel

Introduction

David Andrew Neel is a prominent inventor based in Zionsville, Indiana. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various physiological disorders. With a total of 15 patents to his name, Neel's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents, Neel has developed Tetrahydrocarbazole derivatives that are useful as androgen receptor modulators. This invention provides a compound formula that can be used in pharmaceutical compositions to treat conditions such as frailty, osteoporosis, osteopenia, and sexual dysfunction. Another notable patent involves Retinoid X receptor modulators, which are directed towards compounds represented by a specific structural formula. This invention also includes pharmaceutical compositions and methods for making these compounds.

Career Highlights

Throughout his career, David Andrew Neel has worked with esteemed companies such as Eli Lilly and Company and Ligand Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Neel has collaborated with notable individuals in his field, including John H McDonald, III and Michael Gregory Bell. These partnerships have further enhanced his innovative capabilities and have led to the development of impactful pharmaceutical solutions.

Conclusion

David Andrew Neel's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.